NEW YORK, NY. December 14. The Lupus Research Alliance is pleased to share good news about a potential new treatment for systemic lupus erythematosus (SLE). Yesterday, Eli Lilly and Company and Incyte Corporation announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation to baricitinib, which is being studied for the treatment of SLE. […] READ MORE
Gala Brings Out Heavy Hitters With The Honorable Michael R. Bloomberg, Lady Gaga, and Selena Gomez as honorary chairs, the success of our annual gala on November 19, 2018 — Breaking through Lupus was practically guaranteed. It was an unforgettable, spectacular evening, which brought in $3.5 million for lupus research studies. These big names came […] READ MORE
NEW YORK, NY. December 20. The Lupus Research Alliance is proud to announce the 2018 recipients of the Dr. William E. Paul Distinguished Innovator Award in Lupus and Autoimmunity: Nir Hacohen, PhD (right) and Vijay Kuchroo, DVM, PhD (left). Dr. Hacohen is seeking better ways to treat lupus kidney disease, the major cause of illness and […] READ MORE
November 30, 2018 This event is the brain child of Lupus Research Alliance Board member Nadeem Meghji, whose young niece suffers with lupus. Together with event Co-Chair Donald Provost and committee members Shannon Ching, Rachel Doyon, Andrea Drasites, and David O’Neill — Nadeem created a fun ping pong fundraising event at SPiN New York that has grown in size and stature every year. […] READ MORE
November 28, 2018 Anti-malaria drugs such as hydroxychloroquine are common treatments for arthritis and heat rash in patients with lupus. A new study by Target Identification in Lupus grantee Keith Elkon, MD, of the University of Washington, Seattle, and colleagues suggests that a new drug they designed works better than the commonly prescribed hydroxychloroquine in […] READ MORE
November 27, 2018 Lupus Research Alliance was named by Consumer Reports as one of the best five health organizations to donate to in 2018. This blue-chip recognition is based on ratings by independent watchdog groups like BBB Wise Giving Alliance and CharityWatch. “Choosing charities by name alone is a mistake some donors make, and their money sometimes ends up […] READ MORE
November 19, 2018 The iconic Empire State Building lit up purple and red tonight in honor of the Lupus Research Alliance 2018 Breaking Through Gala. The larger-than-life tribute highlights the need for lupus research to develop new treatments and ultimately a cure for the millions worldwide living with this devastating disease. READ MORE
The Lupus Research Alliance 2018 Breaking Through Gala honored Board member William J. Wolfe, Chairman and CEO of First Washington Realty, Inc. for his instrumental role in uniting the lupus community to an unparalleled global research enterprise. With the generous support of 650 attendees, the evening raised over $3.5 million specifically for lupus research. Mr. […] READ MORE
Patient Involvement: Let Your Story Become Part of CommUnity The Lupus Research Alliance is pleased to invite you to join our new Lupus CommUnity Forum — a place to unite with others who face many of the same struggles you may have experienced. The Lupus CommUnity Forum is where you can discover what others are […] READ MORE
November 15, 2018 Straightforward. Clear. Innovative. These words aptly describe the research that Jillian Richmond, PhD, of the University of Massachusetts Medical School at Worcester, MA, is conducting with a grant from the Lupus Research Alliance. She is looking for ways to stop lupus from damaging healthy tissue. But to attain a better picture of […] READ MORE
November 13, 2018 While much basic autoimmune research has focused on ways to foil the bad behavior of immune cells, Dr. Salmon and her team of investigators at the Hospital for Special Surgery/Weill Cornell Medicine have taken a very different tack. They have been studying whether enhancing the ability of the lining of the blood […] READ MORE
The Lupus Research Alliance supports the full range of research from fundamental through translational and clinical studies. Most recently, the organization awarded six Novel Research Grants and seven Target Identification in Lupus (TIL) grants. PROMISING NOVEL GRANT AWARDS: The Lupus Research Alliance supports game-changing lupus research, and our Novel Research Grant program is exploring lupus […] READ MORE
